What Is the Passerini Reaction? Definition and What Research Reports

Definition

The Passerini reaction is a one-pot, three-component reaction (often abbreviated P-3CR) in which a carboxylic acid, an oxo component (an aldehyde or a ketone) and an isocyanide combine to form an α-acyloxy carboxamide. It is named after the chemist Mario Passerini and is one of the classical isocyanide-based multicomponent reactions of synthetic organic chemistry. Two points are worth separating at the outset: the Passerini reaction is a transformation, not a substance, and the term therefore names a way of making molecules rather than a molecule that could itself be studied in a living system. Its products, α-acyloxy carboxamides, contain both an ester and an amide bond in a single small fragment — an arrangement that structurally resembles a depsipeptide unit, which is why the reaction appears frequently in peptidomimetic and peptide-mimicking chemistry literature.

This page is for educational purposes only and is not medical advice; consult a licensed physician for questions about health, treatment or any substance discussed in the research literature.

What Class of Chemistry It Belongs To

The Passerini reaction belongs to the family of isocyanide-based multicomponent reactions (IMCRs), the same broad family that includes the four-component Ugi reaction. Multicomponent reactions are defined by the fact that three or more starting materials are combined in a single operation and most of their atoms are incorporated into the product, so a large number of distinct compounds can be prepared from a modest set of building blocks. This atom-economical, combinatorial character is the reason the reaction recurs in library synthesis, materials chemistry and medicinal chemistry papers.

Practically, the reaction is usually run without a metal catalyst, often in concentrated or solvent-free conditions, and it tolerates a wide range of functional groups on each of the three inputs. Because each of the three components can be varied independently, the accessible product space grows multiplicatively, and papers in this area routinely describe diversity rather than a single target compound.

Where the Term Appears in Peptide and Peptidomimetic Research

In peptide-adjacent research the Passerini reaction is used in several recurring ways:

• Depsipeptide-like fragments. The ester–amide motif of an α-acyloxy carboxamide is a direct structural analogue of an ester-for-amide backbone substitution.
• Peptidomimetic scaffolds. Researchers examined Passerini chemistry as a route to antimicrobial peptidomimetics directed at nosocomial pathogenic bacteria (PMID 39125898).
• Heterocycle construction. Passerini products have been used as intermediates that are cyclised in subsequent steps into ring systems.
• Polymer and materials backbones. The reaction has been adapted to step-growth polymerisation and to dendrimer construction.
• Library-based medicinal chemistry. The three-component format supports rapid variation of substituents around a common core.

What the Published Literature Reports

Reaction variants and conditions

Method-focused papers have described modifications of the classical three-component format. A 2006 report in Organic Letters described O-arylative Passerini reactions, extending the standard acid/carbonyl/isocyanide combination (PMID 17048833). A 2019 study reported a visible-light-induced Passerini multicomponent polymerization, in which the multicomponent coupling was driven photochemically and applied to polymer synthesis (PMID 30805991). More recently, researchers reported that microdroplet chemistry accelerated the three-component Passerini reaction for the synthesis of α-acyloxy carboxamides (PMID 37493511).

Other work has coupled the Passerini step to downstream transformations. A 2022 paper in the Beilstein Journal of Organic Chemistry described a Passerini/Staudinger/aza-Wittig/addition/nucleophilic substitution sequence that produced polysubstituted 3,4-dihydroquinazolines and 4H-3,1-benzothiazines (PMID 35330780). A separate report described access to benzodioxepinones — a class of oxacycles — via a Passerini reaction (PMID 35900638).

Compound libraries evaluated in biological assays

Several medicinal-chemistry groups have used the reaction to generate screening sets. One study designed, synthesised and biologically evaluated novel α-acyloxy carboxamides prepared by the Passerini reaction as caspase 3/7 activators (PMID 30826510). A methods chapter described the use of the Passerini reaction in drug discovery for soft drugs acting at the TRPV1 and TRPM8 channels (PMID 31028682), and a later paper in the European Journal of Medicinal Chemistry reported that the multicomponent Passerini reaction was used as a means of accessing diversity in structure, activity and properties across soft and hard vanilloid/cannabinoid modulators (PMID 39265249). In the antimicrobial space, a 2024 study examined Passerini-derived peptidomimetics against nosocomial pathogenic bacteria (PMID 39125898).

Polymers, dendrimers and delivery materials

Materials-oriented papers form a third cluster. Researchers reported a divergent dendrimer synthesis that combined the Passerini three-component reaction with olefin cross-metathesis (PMID 24356926). Another study described the facile synthesis and properties of multifunctionalised polyesters prepared by the Passerini reaction and characterised them as thermosensitive, biocompatible and triggerable drug-release carriers (PMID 35026906). A 2024 paper reported a structure–activity relationship study of cationic lipids made by multicomponent Passerini chemistry for non-viral gene delivery (PMID 38340641).

Quick Reference Table

Biological Findings: What Studies Report

Because the Passerini reaction is a synthetic method, the published biological findings attach to the individual compounds it produces rather than to the reaction itself, and they were reported at the level of in vitro and preclinical characterisation. One study reported that Passerini-derived α-acyloxy carboxamides were evaluated as caspase 3/7 activators (PMID 30826510), while another described Passerini-derived polyesters as biocompatible and triggerable drug-release carriers in the characterisation reported by the authors (PMID 35026906). Work on cationic lipids for non-viral gene delivery was framed as a structure–activity relationship investigation rather than a clinical evaluation (PMID 38340641). None of the cited reports described human clinical outcomes, and no safety or tolerability conclusions for people can be drawn from them.

Related Terms and Common Confusions

• Ugi reaction. A related isocyanide multicomponent reaction that adds an amine component and yields a bis-amide; the Passerini reaction has no amine input and yields an ester–amide product.
• Depsipeptide. A peptide-like chain in which one or more amide bonds are replaced by ester bonds; Passerini products contain the same ester–amide pairing in miniature.
• Soft drug. A design concept in which a compound is built to be metabolically degraded in a predictable way; the term appears in Passerini-based TRPV1/TRPM8 work (PMID 31028682).
• Multicomponent polymerization. The extension of a multicomponent reaction to step-growth polymer synthesis (PMID 30805991).

Limitations of the Evidence

The literature summarised here is predominantly synthetic and preclinical. Papers on this topic typically report reaction scope, yields, structural characterisation and, in medicinal-chemistry cases, in vitro assay outcomes. Structural diversity generated by a multicomponent reaction does not by itself indicate biological usefulness, and the cited studies did not evaluate the resulting compounds in humans. Readers comparing sources should note that "Passerini reaction" describes a family of related procedures whose conditions, catalysts and solvents differ substantially between reports.

References

• O-arylative Passerini reactions (Organic Letters, 2006)
• Divergent dendrimer synthesis via the Passerini three-component reaction and olefin cross-metathesis (Macromolecular Rapid Communications, 2014)
• Visible-Light-Induced Passerini Multicomponent Polymerization (Angewandte Chemie International Edition, 2019)
• Facile Synthesis and Properties of Multifunctionalized Polyesters by Passerini Reaction as Thermosensitive, Biocompatible, and Triggerable Drug Release Carriers (ACS Applied Bio Materials, 2019)
• Design, synthesis and biological evaluation of novel α-acyloxy carboxamides via Passerini reaction as caspase 3/7 activators (European Journal of Medicinal Chemistry, 2019)
• Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction (Methods in Molecular Biology, 2019)
• New efficient synthesis of polysubstituted 3,4-dihydroquinazolines and 4H-3,1-benzothiazines through a Passerini/Staudinger/aza-Wittig/addition/nucleophilic substitution sequence (Beilstein Journal of Organic Chemistry, 2022)
• Microdroplet Chemistry Accelerating a Three-Component Passerini Reaction for α-Acyloxy Carboxamide Synthesis (The Journal of Organic Chemistry, 2023)
• New oxacycles on the block: benzodioxepinones via a Passerini reaction (Molecular Diversity, 2024)
• Cationic lipids from multi-component Passerini reaction for non-viral gene delivery: A structure-activity relationship study (Bioorganic & Medicinal Chemistry, 2024)
• The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators (European Journal of Medicinal Chemistry, 2024)
• Mystery of the Passerini Reaction for the Synthesis of the Antimicrobial Peptidomimetics against Nosocomial Pathogenic Bacteria (International Journal of Molecular Sciences, 2024)